[Health] 7.Jan.2022
Guests: Patrick Trucchio, Managing Director & Senior Healthcare Analyst, H.C. Wainwright & Co and Amy Reichelt, Director: Neuropharmachology, Cybin
Research and clinical trials for promising psychedelic therapies are well underway. Patrick Trucchio, Managing Director and Senior Healthcare Analyst of H.C. Wainwright & Co. and Amy Reichelt, Director of Neuropharmacology at Cybin, join Anthony Lacavera to reveal the exciting potential for psychedelic therapies to treat an array of conditions, safely and effectively.
